EU Regulatory Plan Targets Big Pharma Competition, Mergers
The European Commission on Wednesday adopted a plan to develop a regulatory framework by 2022 to increase access to cheap generic drugs by cracking down on anti-competitive behaviors by pharmaceutical companies...To view the full article, register now.
Already a subscriber? Click here to view full article